DURHAM, N.C. (WNCN) – Gov. Pat McCrory announced Tuesday 275 pharma-manufacturing jobs are coming to Durham.
Aurobindo Pharma USA, Inc. said an expansion will bring the R&D jobs to the Bull City.
“We welcome the decision by Aurobindo Pharma to undertake this significant expansion in the Research Triangle,” said McCrory. “Our state is eager to partner with this global company as it embarks on its business objectives and grows its presence in North Carolina’s life sciences community.”
Aurobindo Pharma, a New Jersey-based maker of generic pharmaceuticals, said it will invest more than $31.7 million in a Durham headquarters for specialty pharmaceutical R&D.
The company currently employs 14 in Raleigh.
Following McCrory’s announcement, the North Carolina Democratic Party was quick in their response.
Rep. Larry Hall (D-Durham) said the jobs are a drop in the bucket compared to the economic damage HB2 has caused.
“While I’m thrilled to bring good-paying new jobs to Durham and North Carolina, we need to be clear that today’s announcement represents a fraction of the jobs lost thanks to HB2. Governor McCrory’s support for this discriminatory bill has already cost our state at least 1,750 jobs and more than $77 million in economic damage. Governor McCrory should take action and repeal HB2 so that job announcements like the one today aren’t the exception, but the rule,” said Hall.